Non-NRP2 mRNAs with partial complementarity

The term 'Non-NRP2 mRNAs with partial complementarity' refers to a collection of messenger RNA molecules that are not the intended therapeutic target (Neuropilin-2) but share sufficient sequence similarity to be inadvertently recognized by NRP2-targeted drugs. This phenomenon is primarily relevant to RNA-targeted therapies, such as antisense oligonucleotides (ASOs) and siRNAs, where the drug's specificity is determined by base-pairing rules. When a drug designed for NRP2 binds to these partially complementary off-target transcripts, it can trigger their degradation or inhibit their translation, potentially leading to unintended biological effects or toxicity (Levin, 2019, Nucleic Acid Therapeutics). Identifying these transcripts is a critical component of the lead optimization process in drug development to ensure that the therapeutic agent does not interfere with essential cellular pathways unrelated to the primary disease target. Consequently, this entry does not represent a single biological entity but rather a safety-related classification used during the specificity profiling of oligonucleotide-based medicines.

Other names

Off-target mRNA transcriptsPartial match transcriptsNon-specific hybridization targets

Unintended sequence-specific hybridization of an oligonucleotide drug to non-target mRNA sequences, leading to RNAse H-mediated degradation or translational repression (Jackson et al., 2003, Nature Biotechnology).